Compare IDEXX Laboratories, Inc. (IDXX) vs Energy Select Sector SPDR Fund (XLE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Energy Select Sector SPDR Fund — how do they compare? IDEXX Laboratories, Inc. trades at $567.52 (market cap $44.95B), while Energy Select Sector SPDR Fund trades at $61.05. The key difference: Energy Select Sector SPDR Fund is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| IDXX | XLE | |
|---|---|---|
Market Cap | $44.95B | — |
Sector | Health | — |
52-Week High | $766.68 | $62.57 |
52-Week Low | $526.44 | $42.52 |
Enterprise Value | $45.85B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $566.93, down 3.36% on the day, with a neutral technical signal and strong support near $565. The company reported robust Q2 2026 earnings, beating EPS estimates with $4.27 versus $3.94 expected, and raised full-year EPS guidance to $14.69–14.94. Revenue grew 10% year-over-year, driven by companion animal diagnostics, while profitability remains high with a net margin of 25.03% in 2025. Analyst consensus is bullish with a $683.33 price target, though valuation multiples like P/E of 40.1 suggest a premium.
Outlook is positive due to consistent earnings beats, international expansion, and innovation in veterinary diagnostics, but risks include elevated valuation sensitivity, competitive pressures, and reliance on pet healthcare spending. The stock offers growth potential if execution continues, yet investors should weigh high multiples against sustained profitability trends.
XLE trades at $61.03, up 0.16% with a bullish technical outlook supported by moving averages. The energy ETF has rallied over 40% in the past year, driven by elevated oil prices and strong earnings from major holdings like ExxonMobil and Chevron. Recent geopolitical tensions in the Middle East continue to support energy prices, though the current entry point appears less attractive after the significant run-up.
Outlook remains positive but cautious as the ETF faces geopolitical sensitivity and potential volatility. While strong earnings and oil price support continue, the concentrated exposure to a few large energy companies increases vulnerability to sector-specific risks. Investors should weigh the attractive expense ratio against the sector's inherent cyclicality.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Energy Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →
